TSHA·Nasdaq·US
Taysha Gene Therapies
Taysha Gene Therapies is a clinical-stage biotechnology company focused on adeno-associated virus-based gene therapies for severe monogenic diseases of the central nervous system. Its pipeline centers on lead programs such as TSHA-102 for Rett syndrome and additional CNS gene therapy candidates.
Thematic Position
Relationship Groups
Relationship details are part of the Pro plan.